Health and Fitness Health and Fitness
Thu, December 1, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
Direction of Market Influences - Report Highlights Abbott Laboratories and Novartis AG (ADR)
[ Thu, Dec 01st 2011 ] - Market Wire
Direction of Market Influences - Report Highlight .. ilead Sciences, Inc. and Bristol Myers Squibb Co.
[ Thu, Dec 01st 2011 ] - Market Wire
DiaMedica's DM-204 for Type 2 Diabetes Significan .. od Glucose, Blood Pressure and Cholesterol Levels
[ Thu, Dec 01st 2011 ] - Market Wire
ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188
[ Thu, Dec 01st 2011 ] - Market Wire
Lead Drug Candidates From Galena Biopharma and Ar .. a Pharmaceuticals Look to Make Big Splash in 2012
[ Thu, Dec 01st 2011 ] - Market Wire
Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day
[ Thu, Dec 01st 2011 ] - Market Wire
Equity Research on HEALTHSOUTH Corp. and DaVita I .. lized Health Services Look to Add to Recent Gains
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Confirms First-to-File Patent Challenge Relating to Generessa" Fe
[ Thu, Dec 01st 2011 ] - Market Wire
MedCath Announces Sale of Ownership Interest in Harlingen Medical Center and HMC Realty, LLC
[ Thu, Dec 01st 2011 ] - Market Wire
Stellar to Acquire Tribute Pharmaceuticals to Cre .. r North American Specialty Pharmaceutical Company
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Launches Generic Version of Caduet Tablets
[ Thu, Dec 01st 2011 ] - Market Wire
Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine
[ Thu, Dec 01st 2011 ] - Market Wire
Ceregene Completes Enrollment of Second Phase 2 S .. CERE-120 for the Treatment of Parkinson's Disease
[ Thu, Dec 01st 2011 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces First Pa .. sed in XIAFLEX Study for Frozen Shoulder Syndrome
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Committed to Expanding Access in Developing .. es to High Quality, Affordable HIV/AIDS Treatment
[ Thu, Dec 01st 2011 ] - Market Wire
VIVUS to Present at the Deutsche Bank BioFEST Conference
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Pfizer Completes Acquisition of Ferrosan Consumer Healthas Business
[ Wed, Nov 30th 2011 ] - Market Wire
Santarus Announces Presentation of New Open-Label .. the Crohnas and Colitis Foundation Clinical & Res
[ Wed, Nov 30th 2011 ] - Market Wire
Stereotaxis Enters $20 Million Royalty Financing Agreement
[ Wed, Nov 30th 2011 ] - Market Wire
Teva Announces Agreement with Ranbaxy Regarding Generic Lipitor
[ Wed, Nov 30th 2011 ] - Market Wire
Transcept Pharmaceuticals to Host Conference Call .. of Option to Commercialize Intermezzo in the Uni
[ Wed, Nov 30th 2011 ] - Market Wire
Children's Hospital &;; Medical Center .. ntriPoint Congenital Heart Disease Clinical Trial
[ Wed, Nov 30th 2011 ] - Market Wire
Transcept Pharmaceuticals Announces Purdue's Exer .. to Commercialize Intermezzo in the United States
[ Wed, Nov 30th 2011 ] - Market Wire
The Edwards Lifesciences Fund Supports More Than 200 Charitable Organizations
[ Wed, Nov 30th 2011 ] - Market Wire
Soil Biogenics Limited Announces Restructuring of Its Activities
[ Wed, Nov 30th 2011 ] - Market Wire
Tortoise Pipeline & Energy Fund Announces Initial Distribution
[ Wed, Nov 30th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces a Securities Fra .. Has Been Filed Against The Cooper Companies, Inc.
[ Wed, Nov 30th 2011 ] - Market Wire
CORRECTING and REPLACING Derma Sciences to Present at Upcoming Conferences
[ Wed, Nov 30th 2011 ] - Market Wire
Alere to Attend the Canaccord Genuity 6th Annual .. Metabolic Disorders Medical Devices Conference on
[ Wed, Nov 30th 2011 ] - Market Wire
The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST

The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST


Published on 2011-11-30 13:37:09 - Market Wire
  Print publication without navigation


November 30, 2011 16:30 ET

The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST

PARSIPPANY, NJ--(Marketwire - Nov 30, 2011) - The Medicines Company (NASDAQ: [ MDCO ]) will present at the 2011 Deutsche Bank BioFEST on Monday, December 5th, in Boston beginning at 8:25am Eastern Time. Glenn Sblendorio, Chief Financial Officer and Executive Vice President, will provide a company overview.

The session will be webcast with a link available at The Medicines Company's website [ http://www.themedicinescompany.com ].

About The Medicines Company
The Medicines Company (NASDAQ: [ MDCO ]) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well being of critically ill patients. The Medicines Company's website is [ www.themedicinescompany.com ].


Contributing Sources